Atlas Trials

18F-Floretyrosine Expanded Access Program

Clinical trial NCT06743100 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT06743100
Sponsor
Telix Pharmaceuticals (Innovations) Pty Limited
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Glioma (Any Grade) in the Brain

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.